Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. [electronic resource]
Producer: 20120803Description: 406-10 p. digitalISSN:- 1029-2403
- Adult
- Anemia -- chemically induced
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biotransformation -- genetics
- Bleomycin -- administration & dosage
- Carboplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Dacarbazine -- administration & dosage
- Doxorubicin -- administration & dosage
- Epirubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- Gene Deletion
- Genetic Predisposition to Disease
- Genotype
- Glutathione S-Transferase pi -- genetics
- Glutathione Transferase -- genetics
- Hodgkin Disease -- drug therapy
- Humans
- Lomustine -- administration & dosage
- Male
- Middle Aged
- Neoplasm Proteins -- genetics
- Polymorphism, Genetic
- Polymorphism, Single Nucleotide
- Prednisone -- administration & dosage
- Procarbazine -- administration & dosage
- Prognosis
- Treatment Outcome
- Vinblastine -- administration & dosage
- Vincristine -- administration & dosage
- Vindesine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.